293
Views
15
CrossRef citations to date
0
Altmetric
Research Article

The tyrphostin AG1478 augments oridonin-induced A431 cell apoptosis by blockage of JNK MAPK and enhancement of oxidative stress

, , , , &
Pages 1393-1405 | Received 17 May 2012, Accepted 07 Aug 2012, Published online: 05 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zi-Zhen Xu, Wan-Bin Fu, Zhen Jin, Pei Guo, Wen-Fang Wang & Jun-Min Li. (2016) Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma. Leukemia & Lymphoma 57:4, pages 888-898.
Read now

Articles from other publishers (14)

Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada & Prasad Sanjay Dhiwar. (2023) Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors. Journal of Molecular Structure 1291, pages 136021.
Crossref
Listiana Oktavia, Asrul Muhamad Fuad, Seni Kurnia Senjaya & Yuliawati Yuliyawati. (2023) Naturally Occurring Compounds as Potential Inhibitors of Epidermal Growth Factor Receptors (EGFRs). Combinatorial Chemistry & High Throughput Screening 26:6, pages 1093-1107.
Crossref
Tatsuaki Tsuruyama. (2023) Kullback–Leibler Divergence of an Open-Queuing Network of a Cell-Signal-Transduction Cascade. Entropy 25:2, pages 326.
Crossref
Kaori Kiso-Farnè & Tatsuaki Tsuruyama. (2022) Epidermal growth factor receptor cascade prioritizes the maximization of signal transduction. Scientific Reports 12:1.
Crossref
Ravichandran Rakesh, Loganathan Chandramani PriyaDharshini, Kunnathur Murugesan Sakthivel & Rajan Radha Rasmi. (2022) Role and regulation of autophagy in cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:7, pages 166400.
Crossref
Yuan Liang, Tiehua Zhang & Jie Zhang. (2020) Natural tyrosine kinase inhibitors acting on the epidermal growth factor receptor: Their relevance for cancer therapy. Pharmacological Research 161, pages 105164.
Crossref
Hua Luo, Chi Teng Vong, Hanbin Chen, Yan Gao, Peng Lyu, Ling Qiu, Mingming Zhao, Qiao Liu, Zehua Cheng, Jian Zou, Peifen Yao, Caifang Gao, Jinchao Wei, Carolina Oi Lam Ung, Shengpeng Wang, Zhangfeng Zhong & Yitao Wang. (2019) Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chinese Medicine 14:1.
Crossref
Anupama Tuladhar, Robert J. Hondal, Ricardo Colon, Elyssa L. Hernandez & Kathleen S. Rein. (2019) Effectors of thioredoxin reductase: Brevetoxins and manumycin-A. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 217, pages 76-86.
Crossref
Anupama Tuladhar & Kathleen S. Rein. (2018) Manumycin A Is a Potent Inhibitor of Mammalian Thioredoxin Reductase-1 (TrxR-1). ACS Medicinal Chemistry Letters 9:4, pages 318-322.
Crossref
Xiaoning Liu, Jingjing Kang, Hui Wang & Tao Huang. (2017) Mitochondrial ROS contribute to oridonin-induced HepG2 apoptosis through PARP activation. Oncology Letters.
Crossref
Jiang Pi, Hua Jin, Jinhuan Jiang, Fen Yang, Huaihong Cai, Peihui Yang, Jiye Cai & Zheng W. Chen. (2017) Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells. Pharmacological Research 119, pages 479-489.
Crossref
Hongxia Wang, Jun Qian & Fuyuan Ding. (2017) Recent advances in engineered chitosan-based nanogels for biomedical applications. Journal of Materials Chemistry B 5:34, pages 6986-7007.
Crossref
A. K. Gardner, C. S. Kelly, A. W. van Eps, T. A. Burns, M. R. Watts & J. K. Belknap. (2016) Mitogen-activated kinase pathway activation in epidermal lamellae in the acute stages of carbohydrate overload laminitis models and the effect of regional deep hypothermia on signalling pathways. Equine Veterinary Journal 48:5, pages 633-640.
Crossref
XINBING SUI, NA KONG, MINGHUA ZHU, XIAN WANG, FANG LOU, WEIDONG HAN & HONGMING PAN. (2014) Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non-small-cell lung cancer. Molecular and Clinical Oncology 2:1, pages 8-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.